Skip to main content
NCBI home page
Gut logoLink to Gut
. 2002 May;50(Suppl 3):iii31–iii36. doi: 10.1136/gut.50.suppl_3.iii31

The genetic jigsaw of inflammatory bowel disease

D Watts, J Satsangi
PMCID: PMC1867682  PMID: 11953330

Full Text

The Full Text of this article is available as a PDF (110.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad T., Satsangi J., McGovern D., Bunce M., Jewell D. P. Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther. 2001 Jun;15(6):731–748. doi: 10.1046/j.1365-2036.2001.00981.x. [DOI] [PubMed] [Google Scholar]
  2. Armitage E., Drummond H., Ghosh S., Ferguson A. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet. 1999 May 1;353(9163):1496–1497. doi: 10.1016/S0140-6736(99)00333-5. [DOI] [PubMed] [Google Scholar]
  3. Bayless T. M., Tokayer A. Z., Polito J. M., 2nd, Quaskey S. A., Mellits E. D., Harris M. L. Crohn's disease: concordance for site and clinical type in affected family members--potential hereditary influences. Gastroenterology. 1996 Sep;111(3):573–579. doi: 10.1053/gast.1996.v111.pm8780559. [DOI] [PubMed] [Google Scholar]
  4. Boulton-Jones J. R., Pritchard K., Mahmoud A. A. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy. Aliment Pharmacol Ther. 2000 Dec;14(12):1561–1565. doi: 10.1046/j.1365-2036.2000.00872.x. [DOI] [PubMed] [Google Scholar]
  5. Chapman R. W. Aetiology and natural history of primary sclerosing cholangitis--a decade of progress? Gut. 1991 Dec;32(12):1433–1435. doi: 10.1136/gut.32.12.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cho J. H., Nicolae D. L., Gold L. H., Fields C. T., LaBuda M. C., Rohal P. M., Pickles M. R., Qin L., Fu Y., Mann J. S. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7502–7507. doi: 10.1073/pnas.95.13.7502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colombel J. F., Ferrari N., Debuysere H., Marteau P., Gendre J. P., Bonaz B., Soulé J. C., Modigliani R., Touze Y., Catala P. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology. 2000 Jun;118(6):1025–1030. doi: 10.1016/s0016-5085(00)70354-4. [DOI] [PubMed] [Google Scholar]
  8. Cuffari C., Hunt S., Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut. 2001 May;48(5):642–646. doi: 10.1136/gut.48.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Curran M. E., Lau K. F., Hampe J., Schreiber S., Bridger S., Macpherson A. J., Cardon L. R., Sakul H., Harris T. J., Stokkers P. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology. 1998 Nov;115(5):1066–1071. doi: 10.1016/s0016-5085(98)70075-7. [DOI] [PubMed] [Google Scholar]
  10. Duerr R. H., Barmada M. M., Zhang L., Davis S., Preston R. A., Chensny L. J., Brown J. L., Ehrlich G. D., Weeks D. E., Aston C. E. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet. 1998 Jul;63(1):95–100. doi: 10.1086/301929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Duerr R. H., Barmada M. M., Zhang L., Pfützer R., Weeks D. E. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet. 2000 Apr 3;66(6):1857–1862. doi: 10.1086/302947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Farmer R. G., Michener W. M., Mortimer E. A. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol. 1980 May;9(2):271–277. [PubMed] [Google Scholar]
  13. Hamlin P. J., Komolmit P., Bransfield K., Jones P. F., Smith N. R., Aldersley M. A., Howdle P. D., Markham A. F., Robinson P. A. Identification of multiple candidate genes for IBD susceptibility using high-density transcript mapping in the IBD2 locus on chromosome 12q. Gastroenterology. 1999 Oct;117(4):1029–1031. doi: 10.1016/s0016-5085(99)70376-8. [DOI] [PubMed] [Google Scholar]
  14. Hampe J., Schreiber S., Shaw S. H., Lau K. F., Bridger S., Macpherson A. J., Cardon L. R., Sakul H., Harris T. J., Buckler A. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet. 1999 Mar;64(3):808–816. doi: 10.1086/302294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hashimoto L., Habita C., Beressi J. P., Delepine M., Besse C., Cambon-Thomsen A., Deschamps I., Rotter J. I., Djoulah S., James M. R. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature. 1994 Sep 8;371(6493):161–164. doi: 10.1038/371161a0. [DOI] [PubMed] [Google Scholar]
  16. Hayward P. A., Satsangi J., Jewell D. P. Inflammatory bowel disease and the X chromosome. QJM. 1996 Sep;89(9):713–718. doi: 10.1093/qjmed/89.9.713. [DOI] [PubMed] [Google Scholar]
  17. Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cézard J. P., Belaiche J., Almer S., Tysk C., O'Morain C. A., Gassull M. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):599–603. doi: 10.1038/35079107. [DOI] [PubMed] [Google Scholar]
  18. Hugot J. P., Laurent-Puig P., Gower-Rousseau C., Olson J. M., Lee J. C., Beaugerie L., Naom I., Dupas J. L., Van Gossum A., Orholm M. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996 Feb 29;379(6568):821–823. doi: 10.1038/379821a0. [DOI] [PubMed] [Google Scholar]
  19. Kruglyak L., Lander E. S. Limits on fine mapping of complex traits. Am J Hum Genet. 1996 May;58(5):1092–1093. [PMC free article] [PubMed] [Google Scholar]
  20. Ma Y., Ohmen J. D., Li Z., Bentley L. G., McElree C., Pressman S., Targan S. R., Fischel-Ghodsian N., Rotter J. I., Yang H. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis. 1999 Nov;5(4):271–278. doi: 10.1097/00054725-199911000-00005. [DOI] [PubMed] [Google Scholar]
  21. Negoro K., Kinouchi Y., Hiwatashi N., Takahashi S., Takagi S., Satoh J., Shimosegawa T., Toyota T. Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology. 1999 Nov;117(5):1062–1068. doi: 10.1016/s0016-5085(99)70390-2. [DOI] [PubMed] [Google Scholar]
  22. Ogura Y., Bonen D. K., Inohara N., Nicolae D. L., Chen F. F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R. H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):603–606. doi: 10.1038/35079114. [DOI] [PubMed] [Google Scholar]
  23. Orchard T. R., Thiyagaraja S., Welsh K. I., Wordsworth B. P., Hill Gaston J. S., Jewell D. P. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology. 2000 Feb;118(2):274–278. doi: 10.1016/s0016-5085(00)70209-5. [DOI] [PubMed] [Google Scholar]
  24. Orholm M., Iselius L., Sørensen T. I., Munkholm P., Langholz E., Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ. 1993 Jan 2;306(6869):20–24. doi: 10.1136/bmj.306.6869.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parkes M., Barmada M. M., Satsangi J., Weeks D. E., Jewell D. P., Duerr R. H. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Hum Genet. 2000 Nov 10;67(6):1605–1610. doi: 10.1086/316905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rioux J. D., Silverberg M. S., Daly M. J., Steinhart A. H., McLeod R. S., Griffiths A. M., Green T., Brettin T. S., Stone V., Bull S. B. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet. 2000 Apr 21;66(6):1863–1870. doi: 10.1086/302913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Risch N. J. Searching for genetic determinants in the new millennium. Nature. 2000 Jun 15;405(6788):847–856. doi: 10.1038/35015718. [DOI] [PubMed] [Google Scholar]
  28. Roussomoustakaki M., Satsangi J., Welsh K., Louis E., Fanning G., Targan S., Landers C., Jewell D. P. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997 Jun;112(6):1845–1853. doi: 10.1053/gast.1997.v112.pm9178675. [DOI] [PubMed] [Google Scholar]
  29. Satsangi J., Grootscholten C., Holt H., Jewell D. P. Clinical patterns of familial inflammatory bowel disease. Gut. 1996 May;38(5):738–741. doi: 10.1136/gut.38.5.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Satsangi J., Jewell D. P., Bell J. I. The genetics of inflammatory bowel disease. Gut. 1997 May;40(5):572–574. doi: 10.1136/gut.40.5.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Satsangi J., Parkes M., Louis E., Hashimoto L., Kato N., Welsh K., Terwilliger J. D., Lathrop G. M., Bell J. I., Jewell D. P. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996 Oct;14(2):199–202. doi: 10.1038/ng1096-199. [DOI] [PubMed] [Google Scholar]
  32. Satsangi J., Welsh K. I., Bunce M., Julier C., Farrant J. M., Bell J. I., Jewell D. P. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 1996 May 4;347(9010):1212–1217. doi: 10.1016/s0140-6736(96)90734-5. [DOI] [PubMed] [Google Scholar]
  33. Sawczenko A., Sandhu B. K., Logan R. F., Jenkins H., Taylor C. J., Mian S., Lynn R. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001 Apr 7;357(9262):1093–1094. doi: 10.1016/s0140-6736(00)04309-9. [DOI] [PubMed] [Google Scholar]
  34. Sellon R. K., Tonkonogy S., Schultz M., Dieleman L. A., Grenther W., Balish E., Rennick D. M., Sartor R. B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998 Nov;66(11):5224–5231. doi: 10.1128/iai.66.11.5224-5231.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stokkers P. C., Reitsma P. H., Tytgat G. N., van Deventer S. J. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut. 1999 Sep;45(3):395–401. doi: 10.1136/gut.45.3.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sugimura K., Asakura H., Mizuki N., Inoue M., Hibi T., Yagita A., Tsuji K., Inoko H. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol. 1993 Feb;36(2):112–118. doi: 10.1016/0198-8859(93)90113-f. [DOI] [PubMed] [Google Scholar]
  37. Taylor K. D., Plevy S. E., Yang H., Landers C. J., Barry M. J., Rotter J. I., Targan S. R. ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology. 2001 May;120(6):1347–1355. doi: 10.1053/gast.2001.23966. [DOI] [PubMed] [Google Scholar]
  38. Thompson N. P., Driscoll R., Pounder R. E., Wakefield A. J. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ. 1996 Jan 13;312(7023):95–96. doi: 10.1136/bmj.312.7023.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tysk C., Lindberg E., Järnerot G., Flodérus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988 Jul;29(7):990–996. doi: 10.1136/gut.29.7.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weissenbach J., Gyapay G., Dib C., Vignal A., Morissette J., Millasseau P., Vaysseix G., Lathrop M. A second-generation linkage map of the human genome. Nature. 1992 Oct 29;359(6398):794–801. doi: 10.1038/359794a0. [DOI] [PubMed] [Google Scholar]
  41. Yang H., McElree C., Roth M. P., Shanahan F., Targan S. R., Rotter J. I. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993 Apr;34(4):517–524. doi: 10.1136/gut.34.4.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yang H., Plevy S. E., Taylor K., Tyan D., Fischel-Ghodsian N., McElree C., Targan S. R., Rotter J. I. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut. 1999 Apr;44(4):519–526. doi: 10.1136/gut.44.4.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. de la Concha E. G., Fernandez-Arquero M., Lopez-Nava G., Martin E., Allcock R. J., Conejero L., Paredes J. G., Diaz-Rubio M. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology. 2000 Dec;119(6):1491–1495. doi: 10.1053/gast.2000.20258. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES